These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2844873)

  • 1. Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope.
    Packer M
    J Am Coll Cardiol; 1988 Nov; 12(5):1299-317. PubMed ID: 2844873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of vasodilators and long-term response in heart failure.
    Franciosa JA; Dunkman WB; Leddy CL
    J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.
    Packer M
    J Am Coll Cardiol; 1983 Nov; 2(5):841-52. PubMed ID: 6138375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of positive inotropic agents for chronic heart failure: how have we gone astray?
    Packer M
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):119A-126A. PubMed ID: 8397231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure.
    Packer M
    Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure.
    Tisdale JE; Gheorghiade M
    Am J Cardiol; 1992 Jun; 69(18):34G-47G. PubMed ID: 1626491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical advances in the treatment of congestive heart failure.
    Armstrong PW; Moe GW
    Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with calcium antagonist drugs in congestive heart failure.
    O'Rourke RA; Walsh RA
    Am J Cardiol; 1987 Jan; 59(3):64B-69B. PubMed ID: 3812267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral adaptation in chronic heart failure: therapeutic implications].
    Drexler H
    Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE
    Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
    Cohn JN; Franciosa JA
    Am J Med; 1978 Jul; 65(1):181-8. PubMed ID: 685992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.
    Cohn JN; Ziesche S; Smith R; Anand I; Dunkman WB; Loeb H; Cintron G; Boden W; Baruch L; Rochin P; Loss L
    Circulation; 1997 Aug; 96(3):856-63. PubMed ID: 9264493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs?
    Lang R
    Am Heart J; 1990 Dec; 120(6 Pt 2):1558-64. PubMed ID: 1978981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New positive inotropic drugs for the treatment of congestive heart failure.
    Sonnenblick EH; Mancini DM; LeJemtel TH
    Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of congestive heart failure. An evaluation of recent advances.
    Alpert MA
    Postgrad Med; 1987 May; 81(6):257-67. PubMed ID: 2883640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.